Lakefront Biotherapeutics | GLPG - Resultado Líquido





Resultado Líquido Alterar Data
argenx SE USD 506M 34M 2026-09
AstraZeneca USD 3.12B 610M 2026-09
Biogen USD 97.5M 222M 2026-06
Genmab DKK 303M 250M 2026-06
Gilead Sciences USD -10.5B 12.52B 2026-06
GlaxoSmithKline GBP 1.54B 1.11B 2026-09
GRIFOLS EUR 162M 8M 2026-09
Hikma Pharmaceutical USD 164M 45M 2025-12
Incyte USD -784.8M 1.37B 2026-09
Merck EUR 490M 169M 2026-06
Neurocrine Biosciences USD 206.5M 62.1M 2026-09
Novartis USD 1.2B 2.06B 2026-09
Roche Holding CHF 6.87B 1.4B 2026-06
Sanofi EUR 3.02B 2.68B 2026-09
UCB EUR 1.08B 608M 2025-12
Vertex Pharmaceuticals USD 653.6M 446.2M 2026-09